[1]
Rehman, H.M.Y. et al. 2020. LIPID-LOWERING EFFICACY OF 20 MG SIMVASTATIN VERSUS 5 MG ROSUVASTATIN IN PATIENTS OF TYPE 2 DIABETES. Pakistan Armed Forces Medical Journal. 70, 4 (Aug. 2020), 885–89.